Akiko Todaka

1.5k total citations
80 papers, 688 citations indexed

About

Akiko Todaka is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Akiko Todaka has authored 80 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 41 papers in Pulmonary and Respiratory Medicine and 39 papers in Surgery. Recurrent topics in Akiko Todaka's work include Pancreatic and Hepatic Oncology Research (26 papers), Gastric Cancer Management and Outcomes (23 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Akiko Todaka is often cited by papers focused on Pancreatic and Hepatic Oncology Research (26 papers), Gastric Cancer Management and Outcomes (23 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers). Akiko Todaka collaborates with scholars based in Japan, United States and Germany. Akiko Todaka's co-authors include Akira Fukutomi, Yusuke Onozawa, Hirofumi Yasui, Takahiro Tsushima, Nozomu Machida, Kentaro Yamazaki, Tomoya Yokota, Satoshi Hamauchi, Narikazu Boku and Yukio Yoshida and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Clinical Cancer Research.

In The Last Decade

Akiko Todaka

74 papers receiving 678 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Akiko Todaka Japan	16	390	372	335	91	69	80	688
Ryoji Hyakudomi Japan	17	479 1.2×	326 0.9×	336 1.0×	69 0.8×	34 0.5×	49	775
Xuechao Liu China	17	437 1.1×	416 1.1×	275 0.8×	159 1.7×	124 1.8×	31	770
Yingbo Chen China	15	304 0.8×	422 1.1×	269 0.8×	91 1.0×	138 2.0×	36	723
Méher Ben Abdelghani France	9	334 0.9×	427 1.1×	469 1.4×	70 0.8×	39 0.6×	50	706
Keishi Okubo Japan	12	254 0.7×	254 0.7×	126 0.4×	95 1.0×	88 1.3×	37	502
Yohei Nagai Japan	16	338 0.9×	485 1.3×	552 1.6×	78 0.9×	52 0.8×	57	914
Chihiro Kondoh Japan	13	302 0.8×	241 0.6×	160 0.5×	72 0.8×	35 0.5×	49	546
Victor Hugo Fonseca de Jesus Brazil	12	247 0.6×	173 0.5×	134 0.4×	84 0.9×	40 0.6×	57	410
Keun Wook Lee South Korea	14	499 1.3×	299 0.8×	201 0.6×	40 0.4×	104 1.5×	41	745
T. Crosby United Kingdom	18	373 1.0×	990 2.7×	923 2.8×	55 0.6×	135 2.0×	51	1.3k

Countries citing papers authored by Akiko Todaka

Since Specialization

Citations

This map shows the geographic impact of Akiko Todaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Todaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Todaka more than expected).

Fields of papers citing papers by Akiko Todaka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Todaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Todaka. The network helps show where Akiko Todaka may publish in the future.

Co-authorship network of co-authors of Akiko Todaka

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Todaka. A scholar is included among the top collaborators of Akiko Todaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Todaka. Akiko Todaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Inoue, Toru, et al.. (2024). Cytokine release syndrome treated with tocilizumab following ipilimumab–nivolumab combination therapy in advanced renal cell carcinoma. IJU Case Reports. 8(1). 64–68. 1 indexed citations

Furuse, Junji, Masafumi Ikeda, Makoto Ueno, et al.. (2024). A Phase II Placebo-Controlled Study of the Effect and Safety of Nanvuranlat in Patients with Advanced Biliary Tract Cancers Previously Treated by Systemic Chemotherapy. Clinical Cancer Research. 30(18). 3990–3995. 10 indexed citations

Notsu, Akifumi, Takahiro Tsushima, Takeshi Kawakami, et al.. (2024). Real-world data of anamorelin in advanced gastrointestinal cancer patients with cancer cachexia. BMC Palliative Care. 23(1). 214–214. 2 indexed citations

Ohgi, Katsuhisa, Teiichi Sugiura, Yukiyasu Okamura, et al.. (2023). Long-term adjuvant chemotherapy after resection for pancreatic cancer patients with positive peritoneal lavage cytology. Langenbeck s Archives of Surgery. 408(1). 165–165. 5 indexed citations

Todaka, Akiko, Mitsuhito Sasaki, Hideki Ueno, et al.. (2023). FOLFIRINOX in Pancreatic Cancer: Risk Factors for Febrile Neutropenia and Severe Neutropenia — Nationwide Study Analysis. Anticancer Research. 43(9). 4115–4123. 1 indexed citations

Matsubayashi, Hiroyuki, Akiko Todaka, Hirotoshi Ishiwatari, et al.. (2023). Discordant microsatellite instability findings in two samples from a patient with biliary cancer that responded to pembrolizumab. Clinical Journal of Gastroenterology. 16(5). 748–754. 1 indexed citations

Ohgi, Katsuhisa, Teiichi Sugiura, Takaaki Ito, et al.. (2022). The prognostic impact of ABO blood type in pancreatic cancer: Relevance to adjuvant chemotherapy. Journal of Hepato-Biliary-Pancreatic Sciences. 29(8). 922–931. 3 indexed citations

Todaka, Akiko, Hiroshi Nakase, Hiromichi Shirasu, et al.. (2022). Effectiveness and safety of gemcitabine plus nab-paclitaxel in elderly patients with advanced pancreatic cancer: a single-center retrospective cohort study. Investigational New Drugs. 40(5). 1106–1116. 3 indexed citations

Todaka, Akiko, Satoshi Nara, Fuyuhiko Motoi, et al.. (2022). Postoperative Treatment of Resectable Pancreatic Cancer With Positive Peritoneal Lavage Cytology: A Multicentre Retrospective Study. Anticancer Research. 42(2). 893–902. 1 indexed citations

10.

Matsubayashi, Hiroyuki, Akiko Todaka, Takeshi Kawakami, et al.. (2022). Genetic medicine in companion diagnostics of germline BRCA testing of Japanese pancreatic cancer patients. Journal of Human Genetics. 68(2). 81–86. 7 indexed citations

11.

Todaka, Akiko, Kentaro Yamazaki, Hiromichi Shirasu, et al.. (2021). Efficacy and safety of S-1 following gemcitabine with cisplatin for advanced biliary tract cancer. Investigational New Drugs. 39(5). 1399–1404. 2 indexed citations

12.

Matsumoto, Ippei, Keiko Kamei, Katsuhiro Omae, et al.. (2019). FOLFIRINOX for locally advanced pancreatic cancer: Results and prognostic factors of subset analysis from a nation-wide multicenter observational study in Japan. Pancreatology. 19(2). 296–301. 25 indexed citations

13.

Todaka, Akiko, Nobumasa Mizuno, Masato Ozaka, et al.. (2018). Nationwide Multicenter Observational Study of FOLFIRINOX Chemotherapy in 399 Patients With Unresectable or Recurrent Pancreatic Cancer in Japan. Pancreas. 47(5). 631–636. 13 indexed citations

14.

Sasaki, Mitsuhito, Hironori Ueno, Katsuhiro Omae, et al.. (2017). Risk factors for febrile neutropenia (FN) in unresectable/recurrent pancreatic cancer(PC) patients(pts) receiving FOLFIRINOX (FFX) from JASPAC06 study. Annals of Oncology. 28. v260–v260. 2 indexed citations

15.

Masuishi, Toshiki, Hiroya Taniguchi, Satoshi Hamauchi, et al.. (2017). Efficacy of bevacizumab in combination with doublet chemotherapy as first-line therapy in metastatic colorectal cancer according to KRAS status.. Journal of Clinical Oncology. 35(4_suppl). 744–744. 1 indexed citations

16.

Yoshida, Yukio, Akira Fukutomi, Masaki Tanaka, et al.. (2017). Gastrojejunostomy versus duodenal stent placement for gastric outlet obstruction in patients with unresectable pancreatic cancer. Pancreatology. 17(6). 983–989. 30 indexed citations

17.

Kawakami, Takeshi, Nozomu Machida, Hirofumi Yasui, et al.. (2016). Efficacy and safety of irinotecan monotherapy as third-line treatment for advanced gastric cancer. Cancer Chemotherapy and Pharmacology. 78(4). 809–814. 28 indexed citations

18.

Hamauchi, Satoshi, Takahiro Tsushima, Akiko Todaka, et al.. (2015). Excessive watering eyes in gastric cancer patients receiving S-1 chemotherapy. Gastric Cancer. 19(3). 894–901. 5 indexed citations

19.

Yokota, Tomoya, Yusuke Onozawa, Narikazu Boku, et al.. (2011). S-1 Monotherapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck After Progression on Platinum-based Chemotherapy. Japanese Journal of Clinical Oncology. 41(12). 1351–1357. 8 indexed citations

20.

Shimoyama, Rai, Hirofumi Yasui, Narikazu Boku, et al.. (2009). Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin. Gastric Cancer. 12(4). 206–211. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact